Skip to Main Content

Good morning, everyone, and how are you today? We are doing just fine, thanks to sunny skies brightening the Pharmalot campus. After all, a few birds can be heard chirping and a crisp breeze is wafting by. Moreover, this marks the middle of the week, which means we have managed to survive this far. And this calls for celebration, yes? So please join us as we hoist another cup of delicious stimulation. Remember, no prescription is required. Meanwhile, here are a few items of interest. Have a grand day and drop us a line if you hear something saucy …

Food and Drug Administration scientists say the Johnson & Johnson (JNJ) Covid-19 single-shot vaccine is effective and prevents hospitalizations from the disease, STAT reports. The company also revealed new, encouraging data showing its shot may do a better-than-expected job at protecting patients against new variants of the virus. At the same time, FDA experts say study data, results of which were originally made public in a Jan. 29 press release, includes insufficient information to draw conclusions on efficacy in people older than 75.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


Comments are closed.